Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 3;17(10):3500-3501.
doi: 10.1080/21645515.2021.1933689. Epub 2021 Jul 9.

Can children of the Sputnik V vaccine recipients become symptomatic?

Esmaeil Mehraeen  1 , SeyedAhmad SeyedAlinaghi  2 , Amirali Karimi  3
Affiliations

Can children of the Sputnik V vaccine recipients become symptomatic?

Esmaeil Mehraeen et al. Hum Vaccin Immunother. .

Abstract

Sputnik V is one of the most promising vaccines, utilizing an Adenovirus vector to cause immunity against SARS-CoV-2. Concerns existed against Adenovirus infection with this vaccine, although seemed to be a rare event. In this study, we observed that 15/18 (83%) of the children of the Sputnik V recipients became symptomatic and developed transient fever and chills for 1-2 days starting after 2-5 days following the vaccination of their parents that can be related to an Adenovirus infection. To our knowledge, this is the first study reporting such symptoms in the children of Sputnik V recipients, and the results should be validated by larger studies.

Keywords: Adverse events; COVID-19; SARS-COV-2; Sputnik V; vaccine.

PubMed Disclaimer

References

    1. Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. The Lancet. 2021;397(10275):671–81. doi:10.1016/S0140-6736(21)00234-8. - DOI - PMC - PubMed
    1. Centers for disease control and prevention, General Recommendations on Immunization, Recommendations of the Advisory Committee on Immunization Practices (ACIP), January 28, 2011. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5515a1.html - PubMed
    1. Dela Cruz CS, Pasnick S, Gross JE, Keller J, Carlos WG, Cao B, Jamil S.. Adenovirus infection and outbreaks: what you need to know. Am J Respir Crit Care Med. 2019;199(7):P13–p4. doi:10.1164/rccm.1997P13. - DOI - PubMed
    1. Jones I, Sputnik RP.. V COVID-19 vaccine candidate appears safe and effective. The Lancet. 2021;397(10275):642–43. doi:10.1016/S0140-6736(21)00191-4. - DOI - PMC - PubMed
    1. Almuqrin A, Davidson AD, Williamson MK, Lewis P, Heesom K, Morris S, Gilbert S, Matthews DA. SARS-CoV-2 candidate vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals a normal low range of viral backbone gene expression alongside very high levels of SARS-CoV-2 S glycoprotein expression. Res Square. 2020. [published online Oct 20] (preprint). doi:10.21203/rs.3.rs-94837/v1. - DOI - PMC - PubMed